ResMed
312 hedge funds and large institutions have $3.87B invested in ResMed in 2014 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 93 increasing their positions, 130 reducing their positions, and 31 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
12% more call options, than puts
Call options by funds: $30.8M | Put options by funds: $27.5M
8% more capital invested
Capital invested by funds: $3.58B → $3.87B (+$291M)
6% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 31
2% less funds holding
Funds holding: 318 → 312 (-6)
2.12% less ownership
Funds ownership: 56.63% → 54.51% (-2.1%)
28% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 130
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$71.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$35.9M |
| 3 |
ICP
Indus Capital Partners
New York
|
+$17.3M |
| 4 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$7.14M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
-$41.8M |
| 2 |
UIM
USS Investment Management
London,
United Kingdom
|
-$35.2M |
| 3 |
LCG
Luxor Capital Group
New York
|
-$35.1M |
| 4 |
GAM
Gotham Asset Management
New York
|
-$25.4M |
| 5 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$23.9M |
RMD Hedge Fund Activity: Q2 2014 in Review
312 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q2 2014, worth a combined $3.87B — up 8.1% from $3.58B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of RMD and 29 opened new positions — a net loss of 2 holders — while 130 trimmed existing stakes and 93 added.
The largest buyer was Macquarie Group, adding an estimated $71.6M. The largest seller was Bank of New York Mellon, cutting an estimated $41.8M.
- 312 institutional investors held ResMed (RMD) as of Q2 2014, down from 318 in Q1 2014.
- Funds reported $3.87B of ResMed stock for Q2 2014, up 8.1% quarter-over-quarter.
- 29 funds opened new ResMed positions in Q2 2014 and 31 closed out, a net change of -2 holders.
- The largest ResMed buyer in Q2 2014 was Macquarie Group, an estimated $71.6M added.
- The largest ResMed seller in Q2 2014 was Bank of New York Mellon, an estimated $41.8M sold.
Based on aggregated 13F filings for Q2 2014.